MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
NAOV - NanoVibronix Inc
$1.28
-0.15(-10.49%)6:57:21 PM 1/27/2021
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.
Stock Chart

Summary:

  • RSI is at a high level of 76. A high level of RSI indicates the stock is overbought.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news

    01/22/2021NAOV
    NAOV Stock: 7 Things to Know About Medical Device Company NanoVibronix

    NanoVibronix (NASDAQ:NAOV) stock is soaring higher on Friday after releasing a filing with the U.S. Securities and Exchange Commission (SEC). Source: Shutterstock The filing from NanoVibronix notes that it has entered into an agreement with existing accredited investors to exercise some of their outstanding warrants. That includes 1,205,967 shares of NAOV stock at a price of $1.165. The agreement also grants these investors another 1,205,967 warrants with an exercise price of $1.04 per share. Th...

    01/19/2021NAOV
    NanoVibronix Issues Letter to Shareholders

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a year in review and vision for 2021.

    12/11/2020NAOV
    NanoVibronix Amends and Expands Distribution Agreement for Its PainShield® and PainShield Plus®

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc. ("UPPI"). Under the terms of the new agreement, which extend the term and increase minimum purchase requirements, UPPI will be the exclusive distributor of privately labeled PainShield® and Pain...

    12/8/2020NAOV
    NanoVibronix Announces UroShield and PainShield Meet New Zealand Medicines and Medical Devices Safety Authority Regulatory Requirements

    NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield and PainShield meet the New Zealand Medical Devices Safety Authority regulatory requirements and have been added to the official WAND database in accordance with the Regulations. Coupled with this approval, the company signed an agreement, and fulfilled its first shipment, with Obex Medical...

    12/7/2020NAOV
    NanoVibronix Announces Closing of $6.0 Million Private Placement Priced At-the-Market

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the closing of its previously announced private placement of 8,571,429 shares of common stock (or common stock equivalents) at a purchase price of $0.70 per share that was priced "at-the-market" under Nasdaq Rules and resulted in gross proceeds of approximately $6.0 million before the deduction...

    12/2/2020NAOV
    NanoVibronix Announces $6.0 Million Private Placement

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into securities purchase agreements with certain institutional and accredited investors to raise $6.0 million through the issuance of 8,571,429 shares of its common stock (or common stock equivalents) at a purchase price of $0.70 per share in a private placement. The closing...

    12/2/2020NAOV
    Independent Study Finds Significant Benefits Provided by NanoVibronix’s UroShield® Device

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive findings from an independent evaluation of its UroShield® device on patients who have used the device for up to two years. The results have been submitted to the National Institute for Health and Care Excellence (NICE) for review and consideration.